“Sickle Cell Disease Therapy: Past, Present, and Future”

Friday, September 8, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first served basis

Presented by:

Rita D. Paschal, M.D.

Assistant Professor, Department of Medicine

Division of Hematology/Oncology

University of Alabama at Birmingham

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Describe the mechanisms by which vaso-occlusion can be modified
• Define the currently FDA approved therapies for sickle cell disease
• Discuss new pharmacologic therapies on the horizon

  “Speaker, Doctor Rita Paschal, has no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

  The Planning Committee members: Dr. James Foran, Dr. Kabir Mody, Jennifer Gatchell, Valerie Fernandez, and Linda Gibson have no relevant financial relationships to disclose.

  Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326)

  For further information, contact  Jen Gatchell 3-2795